- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01675869
Executive Function/Metacognitive Training for At-Risk Preschoolers (ETAM)
February 2, 2017 updated by: Children's Hospital Medical Center, Cincinnati
The purpose of this study is to see if an intervention training executive functions like attention, working memory, and self-regulation for preschoolers at risk for Attention-Deficit/Hyperactivity Disorder is feasible, acceptable to families, and improves attention, behavior, and functioning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Disruptive behavior disorders, particularly Attention-Deficit/Hyperactivity Disorder (ADHD), constitute one of the most common diagnoses in preschool children.
Disruptive behaviors are a major public health problem including causing significant emotional distress for caregivers and children, expulsion from daycare or early education settings, demands on caregiver's time, accident proneness and other safety concerns.
However, few evidence-based early interventions exist for preschoolers with attention and behavior problems, which is critical because they are strongly suggested as the first line of treatment for preschoolers with ADHD.
Because executive functioning (EF) has been consistently been proposed as a putative factor in the development of disruptive behavior disorders an intervention targeting EF (e.g., inhibition, working memory), attention, and metacognition during early childhood could likely affect the development of disruptive behavior disorders in preschoolers.
Indeed, EF skills are identified by kindergarten teachers as primary prerequisites for school success.
EF deficits independently contribute to poorer outcomes in ADHD, and have been linked directly to academic and social functioning deficits.
Given that EF and brain development are rapidly developing during the preschool years, preschoolers may benefit most from an early intervention targeting EF skills.
Investigators have developed a promising intervention, Executive Training of Attention and Metacognition (ETAM), for preschoolers, and have conducted a small preliminary open trial demonstrating the initial acceptability of the intervention.
Investigators also found significant moderate effect sizes on objective measures of EF and moderate to large effect size reductions in ratings of inattention and behavioral symptoms by parents, clinicians, and teachers.
A randomized clinical trial (RCT) is needed to investigate if these positive effects on executive functioning, attention, and behavior are due to ETAM or to the effect of parental attention and/or a placebo effect.
Investigators propose to assess the feasibility of a design for a future RCT.
Investigators will develop an attention control (AC) comparison group and assess the feasibility of: identifying, enrolling and retaining preschoolers at-risk for ADHD, randomization choices, the measurement of EF and functional outcomes, and delivery protocol for both AC and ETAM by conducting a pilot RCT with 60 children at-risk for ADHD.
Exploratory aims include assessing whether children in the ETAM group show gains compared to those in AC on targeted (trained) outcomes (i.e., measures of EF) and untrained outcomes (i.e., ADHD symptoms, academic readiness, social competence).
Investigators will also assess whether gains are maintained as well as investigate potential moderators/mediators.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 5 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female, ages 3.0-4.11 years
- Outpatients, enrolled in a structured educational setting
- At risk for ADHD
- Parent or teacher rated BRIEF T-score > 60 on at least 1 subscale
- Not in other psychosocial interventions
- Medication free at time of the intervention
- English-speaking
Exclusion Criteria:
- Children with significant impairment will be referred for more intensive treatment.
- Pervasive developmental disorders
- Serious head injury or unstable medical or neurological conditions
- Judged by one of the investigators to be acutely suicidal or homicidal, or at imminent risk of injuring self or others or causing significant damage to property
- Children with an Intelligence Quotient (IQ) <85 will be excluded to avoid confounds related to intellectual functioning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: ETAM group
Executive Function/Metacognitive Training Program: An 8-week program, which addresses major areas of deficit in ADHD; namely, attention (the ability to concentrate and focus), inhibition (the ability to control ones behaviors), and memory (the ability to remember information).
|
ETAM is an 8-week intervention involving weekly concurrent child (n=~6 per group) and parent intervention groups.
The ETAM groups will be 1 hour in length (except for the first session which will be 2 hours).
|
|
ACTIVE_COMPARATOR: Attention Control
Attention control group: An 8-week program which provides education regarding several topics relevant for preschool children including nutrition, sleep, temperament, etc.
|
Attention Control is an 8-week intervention involving weekly concurrent child (n=~6 per group) and parent groups that control for the effects of attention.
The groups will be 1 hour in length (except for the first session which will be 2 hours).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive Functioning
Time Frame: 2 month follow-up
|
Investigators will compute an aggregated measure of EF deficits.
For each EF measure investigators will define a threshold for adequate performance as a score obtained by 75% of the children.
Performance will be dummy-coded according to this threshold as "0" for adequate performance and "1" for poor performance.
We will then calculate a continuous measure of EF ranging from 0 (adequate performance on all) to 9 (poor performance on all), by summing the dummy coded scores of all EF measures.
|
2 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (ACTUAL)
June 1, 2015
Study Completion (ACTUAL)
June 1, 2016
Study Registration Dates
First Submitted
July 10, 2012
First Submitted That Met QC Criteria
August 29, 2012
First Posted (ESTIMATE)
August 30, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
February 3, 2017
Last Update Submitted That Met QC Criteria
February 2, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH095911 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Louisiana State University Health...Recruiting
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Executive Training of Attention and Metacognition (ETAM)
-
Tel Aviv UniversityCompletedAttention Deficit Hyperactivity DisorderIsrael
-
Queens College, The City University of New YorkCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Queens College, The City University of New YorkCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of California, San DiegoEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Alexandria UniversityCompletedExecutive Dysfunction | Learning DisordersEgypt
-
Chen LiSouthwest University, ChinaRecruiting
-
Hamad General HospitalUniversiti Sultan Zainal AbidinRecruitingAutism Spectrum DisorderQatar
-
Memorial Sloan Kettering Cancer CenterRutgers UniversityCompletedCentral Nervous System LymphomaUnited States
-
Universidad Católica San Antonio de MurciaCompletedOverweight and Obesity